Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

Inozyme Pharma Inc. Common Stock · INZY

INZYNASDAQCommon stockHistorical · closed Jul 1, 2025CIK 1693011Updated Nov 16, 2026

Company: Inozyme Pharma, Inc. →

Name history
Inozyme Pharma, LLC · through Jan 5, 2017

INZY price & chart

Provider market data
Historical security

This listing closed Jul 1, 2025. Live provider charts are shown only for current listings.

About the company

Inozyme Pharma is a clinical-stage biopharmaceutical company, with approximately 50 employees based in Boston. The company is dedicated to developing innovative therapeutics that target the PPi-Adenosine Pathway, a key regulator of bone health and blood vessel function. Disruptions in this pathway underlie a range of severe diseases, including ENPP1 Deficiency. Our lead investigational therapy, INZ-701, is an ENPP1 Fc fusion protein enzyme replacement therapy designed to restore pyrophosphate and adenosine levels. INZ-701 is currently in late-stage clinical development in ENPP1 Deficiency, with the potential to expand into additional indications where deficiencies in the Pyrophosphate-Adenosine Pathway contribute to disease pathology, including ABCC6 Deficiency and calciphylaxis. Through our pioneering work, we aim to transform treatment options for patients affected by these devastating conditions.

DEFA14A · 2025-06-23 · 0001193125-25-143826

Company description from the cited filing.

Financials

FY 2024 · USD
Revenue— · FY 2024
Net income-102,024,000USD · FY 2024
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

Operating income-104,030,000USD · FY 2024
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

Diluted EPS-1.62USD per share · FY 2024
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemFY 2024FY 2023FY 2022FY 2021
ASSETS
AssetsUSD123,182,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

200,847,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

139,195,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

123,541,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Property, Plant and Equipment, NetUSD784,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

1,466,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

2,018,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

2,383,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD21,081,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

34,588,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

32,915,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

23,316,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Assets, CurrentUSD120,676,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

196,250,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

131,393,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

115,342,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Prepaid Expense and Other Assets, CurrentUSD7,278,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

7,661,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

3,527,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

3,541,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Operating Lease, Right-of-Use AssetUSD562,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

1,126,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

1,620,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

2,053,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Other Assets, NoncurrentUSD——354,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

—
LIABILITIES AND EQUITY
LiabilitiesUSD65,356,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

60,368,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

20,801,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

14,273,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Stockholders’ equity:
Preferred Stock, Value, IssuedUSD0
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

0
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

0
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

0
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Common Stock, Value, IssuedUSD6,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

6,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

4,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

2,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Retained Earnings (Accumulated Deficit)USD-387,954,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

-285,930,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

-214,761,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

-147,700,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD69,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

41,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

-205,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

18,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Stockholders' Equity Attributable to ParentUSD57,826,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

140,479,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

118,394,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

109,268,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Additional Paid in Capital, Common StockUSD445,705,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

426,362,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

333,356,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

256,948,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Liabilities and EquityUSD123,182,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

200,847,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

139,195,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

123,541,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Current liabilities:
Liabilities, CurrentUSD33,898,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

14,686,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

14,715,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

11,633,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Operating Lease, Liability, CurrentUSD913,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

910,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

816,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

731,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Accounts Payable, CurrentUSD2,530,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

1,166,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

2,544,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

2,394,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Operating Lease, Liability, NoncurrentUSD0
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

913,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

1,823,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

2,640,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Other Liabilities, NoncurrentUSD—0
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

124,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

—
Additional Financial Items
Accrued Liabilities, CurrentUSD15,953,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

12,610,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

11,355,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

8,508,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Cash, Cash Equivalents, and Short-term InvestmentsUSD113,100,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

188,600,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

127,900,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

111,800,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Long-term DebtUSD31,458,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

44,769,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

4,139,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

—
Short-term InvestmentsUSD92,006,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

154,001,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

94,951,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

88,485,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemFY 2024FY 2023FY 2022FY 2021
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD-102,024,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

-71,169,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

-67,061,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

-56,624,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization————
Share-based Payment Arrangement, Noncash ExpenseUSD7,945,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

7,037,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

7,672,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

7,164,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts PayableUSD1,364,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

-1,378,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

150,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

-675,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD-91,907,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

-70,675,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

-57,761,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

-48,153,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD66,998,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

-53,646,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

-5,403,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

42,796,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Payments to Acquire Property, Plant, and EquipmentUSD62,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

298,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

410,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

397,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD11,398,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

125,969,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

72,788,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

609,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——9,624,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

-4,748,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD4,350,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

2,347,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

170,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

—
Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD7,945,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

7,000,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

7,700,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

—
Cash, Cash Equivalents, and Short-term InvestmentsUSD113,100,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

As of 2024-12-31

188,600,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

As of 2023-12-31

127,900,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

As of 2022-12-31

111,800,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

As of 2021-12-31

Debt Securities, Available-for-sale, Realized Gain (Loss)USD0
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

0
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

DepreciationUSD742,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

833,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

744,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

674,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Foreign Currency Transaction Gain (Loss), RealizedUSD——18,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

-26,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Gain (Loss) on Disposition of Property Plant EquipmentUSD——-17,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

—
General and Administrative ExpenseUSD20,799,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

20,798,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

20,826,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

18,926,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Income Tax Expense (Benefit)USD0
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

0
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

InterestExpenseNonoperatingUSD5,558,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

———
Investment Income, InterestUSD7,666,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

7,837,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

1,933,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

211,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Net Income (Loss) Attributable to ParentUSD-102,024,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

-71,169,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

-67,061,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

-56,624,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Nonoperating Income (Expense)USD2,006,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

4,476,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

1,614,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

22,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Operating ExpensesUSD104,030,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

75,645,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

68,675,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

56,646,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Operating Lease, ExpenseUSD700,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

900,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

700,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

700,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Operating Lease, Impairment LossUSD564,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

494,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

433,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

378,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Other Nonoperating Income (Expense)USD-102,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

-28,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

-319,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

-189,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Proceeds from Issuance of Common StockUSD10,521,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

85,647,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

56,137,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

—
Proceeds from Issuance of Long-term DebtUSD0
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

40,000,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

4,050,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

—
Proceeds from Stock Options ExercisedUSD596,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

116,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

359,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

609,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2024FY 2023FY 2022FY 2021
Operating Income (Loss)USD-104,030,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

-75,645,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

-68,675,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

-56,646,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Other Nonoperating Income (Expense)USD-102,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

-28,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

-319,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

-189,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Income Tax Expense (Benefit)USD0
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

0
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Net Income (Loss) Attributable to ParentUSD-102,024,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

-71,169,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

-67,061,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

-56,624,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Earnings Per Share, BasicUSD per share-1.62
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

-1.37
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

-1.78
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

—
Earnings Per Share, DilutedUSD per share-1.62
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

-1.37
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

-1.78
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

—
Weighted Average Number of Shares Outstanding, Basicshares62,811,814
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

51,839,131
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

37,763,168
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

—
Weighted Average Number of Shares Outstanding, Dilutedshares62,811,814
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

51,839,131
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

37,763,168
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

—
Interest Expense (non-operating)USD5,558,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

———
Additional Financial Items
Depreciation, Depletion and Amortization, NonproductionUSD700,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

800,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

744,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

674,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Foreign Currency Transaction Gain (Loss), RealizedUSD——18,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

-26,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

General and Administrative ExpenseUSD20,799,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

20,798,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

20,826,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

18,926,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Interest ExpenseUSD—3,333,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

——
Investment Income, InterestUSD7,666,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

7,837,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

1,933,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

211,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Management Fee ExpenseUSD———400,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Nonoperating Income (Expense)USD2,006,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

4,476,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

1,614,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

22,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Operating ExpensesUSD104,030,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

75,645,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

68,675,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

56,646,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Operating Lease, ExpenseUSD700,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

900,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

700,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

700,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Research and Development ExpenseUSD83,231,000
Source

10-K · 2025-03-10 · 0000950170-25-035940

2024-01-01 to 2024-12-31

54,847,000
Source

10-K · 2024-03-12 · 0000950170-24-029673

2023-01-01 to 2023-12-31

47,849,000
Source

10-K · 2023-03-22 · 0000950170-23-009053

2022-01-01 to 2022-12-31

37,720,000
Source

10-K · 2022-03-15 · 0000950170-22-003789

2021-01-01 to 2021-12-31

Lines labelled “Derived” are calculated from reported figures.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.